Enzymatic Method, Creatinine

Device Code: 390

Product Code(s): JFY

Device Classification Information

Device Type ID390
Device NameEnzymatic Method, Creatinine
Regulation DescriptionCreatinine Test System.
Regulation Medical SpecialtyClinical Chemistry
Review PanelClinical Chemistry
Premarket Review Office Of In Vitro Diagnostics And Radiological Health (OIR)
Submission Type510(k)
CFR Regulation Number862.1225 [🔎]
FDA Device ClassificationClass 2 Medical Device
Product CodeJFY
GMP ExemptNo
Summary MREligible
Implanted DeviceNo
Life Support DeviceNo
Third Party Review Eligible For Accredited Persons Program

Recognized Standards

Total Product Life Cycle

Device Type ID390
DeviceEnzymatic Method, Creatinine
Product CodeJFY
FDA Device ClassificationClass 2 Medical Device
Regulation DescriptionCreatinine Test System.
CFR Regulation Number862.1225 [🔎]
Premarket Reviews
ManufacturerDecision
ACON LABORATORIES, INC.
 
SUBSTANTIALLY EQUIVALENT
1
ELITECH GROUP
 
SUBSTANTIALLY EQUIVALENT
1
INSTRUMENTATION LABORATORY
 
SUBSTANTIALLY EQUIVALENT
1
INSTRUMENTATION LABORATORY CO.
 
SUBSTANTIALLY EQUIVALENT
1
ORTHO-CLINICAL
 
SUBSTANTIALLY EQUIVALENT
1
ORTHO-CLINICAL DIAGNOSTICS, INC.
 
SUBSTANTIALLY EQUIVALENT
1
Device Problems
Adverse Event Without Identified Device Or Use Problem
36
Mechanical Problem
24
High Test Results
16
Low Test Results
14
Insufficient Information
11
Device Issue
6
Device Ingredient Or Reagent
5
Non Reproducible Results
4
Incorrect Or Inadequate Test Results
3
Washer
1
Device Ingredient Or Reagent Problem
1
Total Device Problems 121
Recalls
Manufacturer Recall Class Date Posted
1
Beckman Coulter Inc.
II May-12-2017
2
Ortho-Clinical Diagnostics
III Sep-19-2018
3
Ortho-Clinical Diagnostics
II Apr-23-2014
4
Roche Diagnostics Operations, Inc.
II Jun-27-2015
5
Sentinel CH SPA
II Jun-27-2017
6
Siemens Healthcare Diagnostics, Inc.
II May-11-2016
7
Siemens Healthcare Diagnostics, Inc.
II Sep-05-2015
TPLC Last Update: 2019-04-02 19:33:54

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.